Cookies

We use cookies to ensure that we give you the best experience on our website. You can change your cookie settings at any time. Otherwise, we'll assume you're OK to continue.

Durham Business & Innovation Services

2011

Durham University spin-out company reinnervate wins international technology award

(9 August 2011)

Reinnervate, an innovative biotechnology company founded by Professor Stefan Przyborski of Durham University's School of Biological and Biomedical Sciences, is delighted to announce that alvetex®, its breakthrough 3D cell structure technology, is among the winners of the prestigious 49th Annual R&D 100 Awards.


Professor Przyborski's company assists in the funding of eight research PhDs  in the  School of Biological and Biomedical Sciences and the Department of Chemistry,  with a view to benefiting from the technology that the students help to develop. In collaboration, reinnervate then further builds on the research, developing products here in the UK so that they are ready for the international bio-tech market.

Alvetex® is a unique and proprietary cell structure scaffold that, for the first time, enables genuine 3D cell growth to be performed routinely and cost effectively in cell biology laboratories.

Alvetex® was chosen by an independent judging panel and the editors of R&D Magazine to be among the 100 most technologically significant products introduced into the marketplace over the past year. The award will be presented to reinnervate at a special Gala Awards Banquet at the Renaissance Orlando Hotel at SeaWorld in Florida on Thursday 13 October 2011.

Professor Stefan Przyborski, reinnervate's Chief Scientific Officer and founder, said: "We are extremely proud that alvetex® has been selected as one of this year's winners of the annual R&D 100 Awards.

"The team here at reinnervate and at Durham University have shown great dedication in bringing our game-changing alvetex® technology to market and this award goes some way towards recognising their work. Here at reinnervate we continue to innovate and intend to launch further alvetex® products onto the market over the next 12 months, including a 96-well plate suitable for high-throughput drug screening."

Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market, many of which have become household names. Winners are picked from industry sectors as diverse as telecommunications, high-energy physics, software, manufacturing, and biotechnology and represent a cross-section of industry, academia, private research firms and government labs.

Reinnervate was founded in 2002 based on the pioneering research of Professor Stefan Przyborski and his colleagues at Durham University, UK, and is funded by NorthStar Equity Investors (NSEI), management and private investors.

Alvetex® was also named as one of the top ten life science innovations of 2010 by The Scientist magazine.

More news items